We are monitoring the impact of COVID-19 on North America Point of Care (POC) Diagnostics/Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1481
Share on
Share on

North America Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User & Country (the United States, Canada and Rest of North America) - Size, Share, Trends, Growth Opportunities Assessment, COVID-19 Impact & Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1481
Pages: 148

North America POC Diagnostics Market Size (2021 to 2026)

The size of the North America POC Testing Market was worth USD 8.96 billion in 2021 and estimated to reach USD 14.21 billion by the end of 2026, with a CAGR of 9.66%.

The need for POC diagnostics is largely driven by growing illness prevalence, leading to increased demand for improved treatment and quick diagnostic services, and clinical laboratory staff shortages. The rising incidence of chronic and infectious diseases such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) is driving the North America point of care diagnostics market. Furthermore, changes in lifestyle habits contribute to various medical problems, including diabetes, hypertension, and obesity, which need the use of point-of-care diagnostic equipment for diagnosis and monitoring. The North American point of care diagnostics market provides substantial development potential for both established and new product manufacturers. The point of care diagnostics market is growing due to technological advances in POC devices, the rising prevalence of infectious diseases, and increased expenditures by major companies.

The growing adoption rate of POC devices to acquire rapid findings for instant decision-making inpatient care is projected to open up lucrative growth opportunities for the market. Furthermore, regulatory measures for patient care management and the growing prevalence of various diseases are expected to drive demand for these goods in the future years. Furthermore, the growing importance of point-of-care diagnostics in environmental monitoring and public health necessitates integrating technologies that allow for seamless networking, making it even easier for healthcare providers to interpret test findings properly. Thus, in the future year, remote access integration of POC testing and their networking is projected to offer new business opportunities. Other key factors likely to drive the long-term growth of the point-of-care diagnostics market in the future include the rising prevalence of other respiratory illnesses around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices through online platforms.

For healthcare facilities with significant test volumes, these devices are expensive. This is likely to restrict the North American POC testing market expansion, particularly in emerging markets. In addition, manufacturers must submit performance data to the FDA for approval of any new POC device in the United States. POC tests developed for point-of-laboratory (POL) testing require extra onsite performance data and particular FDA recognition. The imposition of such strict rules may constitute a substantial hindrance to market expansion.

This market research report on the North America POC Diagnostics Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Infectious Diseases
  • Cardiac Markers
  • Oncology Markers
  • OTC Diagnostic Tests
  • Drugs Of Abuse
  • Blood Gas Testing
  • Fertility Testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose Monitoring
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry 

By End-User: 

  • Clinics
  • Hospitals
  • Home Healthcare
  • Ambulatory Care Settings
  • Laboratories

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, North America is expected to dominate the overall market in the next five years due to premium healthcare infrastructure, established reimbursement framework, and high healthcare affordability. Moreover, high levels of awareness amongst the patient population base and the physicians associated with fast disease diagnosis are supportive in the industrial revenue.

North America presently maintains the greatest market share because of the significant concentration of important industry suppliers and favorable government efforts targeted at supporting the adoption of a patient-centric care strategy. However, with the rising incidence and prevalence of lifestyle illnesses, North America is gaining traction. More awareness of self-testing and home care goods and substantial adoption of innovative technologies are anticipated to play a vital role in driving the growth of the point of care diagnostics market in North America. Due to the rising use of sophisticated Point-of-Care (POC) diagnostics systems to identify numerous infectious illnesses. Collaborations and strategic alliances among major companies are also contributing elements to the North American region's growth. Due to rapidly growing COVID-19 cases in the United States and Canada, the area will maintain its leading position throughout the predicted years. The number of COVID-19 tests performed in this region exceeded 300 million, indicating enormous market potential.

KEY MARKET PLAYERS:

A few notable companies dominating the North American POC testing market are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  2. North America Infectious Diseases Market By Region, From 2021 to 2026 (USD Billion)
  3. North America Cardiac Markers Market By Region, From 2021 to 2026 (USD Billion)
  4. North America Oncology Markers Market By Region, From 2021 to 2026 (USD Billion)
  5. North America OTC Diagnostic Tests Market By Region, From 2021 to 2026 (USD Billion)
  6. North America Drugs Of Abuse Market By Region, From 2021 to 2026 (USD Billion)
  7. North America Blood Gas Testing Market By Region, From 2021 to 2026 (USD Billion)
  8. North America Fertility Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. North America Urinalysis Market By Region, From 2021 to 2026 (USD Billion)
  10. North America Coagulation Market By Region, From 2021 to 2026 (USD Billion)
  11. North America Hematology Market By Region, From 2021 to 2026 (USD Billion)
  12. North America Glucose Monitoring Market By Region, From 2021 to 2026 (USD Billion)
  13. North America Ambulatory Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  14. North America Decentralized Clinical Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  15. North America Others Market By Region, From 2021 to 2026 (USD Billion)
  16. North America Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  17. North America Clinics Market By Region, From 2021 to 2026 (USD Billion)
  18. North America Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. North America Home Healthcare Market By Region, From 2021 to 2026 (USD Billion)
  20. North America Ambulatory Care Settings Market By Region, From 2021 to 2026 (USD Billion)
  21. North America Laboratories Market By Region, From 2021 to 2026 (USD Billion)
  22. North America Others Market By Region, From 2021 to 2026 (USD Billion)
  23. North America Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  24. North America OTC Market By Region, From 2021 to 2026 (USD Billion)
  25. North America Prescription Market By Region, From 2021 to 2026 (USD Billion)
  26. United States Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  27. United States Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  28. United States Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  29. Canada Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  30. Canada Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  31. Canada Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample